Boston Scientific Corp [NYSE: BSX] closed the trading session at $90.45.
The stocks have a year to date performance of 56.46 percent and weekly performance of 2.23 percent. The stock has been moved at 20.02 percent over the last six months. The stock has performed 2.70 percent around the most recent 30 days and changed 15.25 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 5.71M shares, BSX reached to a volume of 9010355 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Boston Scientific Corp [BSX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BSX shares is $98.32 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BSX stock is a recommendation set at 1.51. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Boston Scientific Corp shares, keeping their opinion on the stock as Hold, with their previous recommendation back on October 18, 2024. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on May 30, 2024, representing the official price target for Boston Scientific Corp stock. Previously, the target price had yet another raise from $65 to $80, while Mizuho kept a Buy rating on BSX stock.
The Average True Range (ATR) for Boston Scientific Corp is set at 1.80, with the Price to Sales ratio for BSX stock in the period of the last 12 months amounting to 8.32. The Price to Book ratio for the last quarter was 6.44, with the Price to Cash per share for the same quarter was set at 1.76. Price to Free Cash Flow for BSX in the course of the last twelve months was 61.41 with Quick ratio for the last quarter at 1.02.
BSX stock trade performance evaluation
Boston Scientific Corp [BSX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.23. With this latest performance, BSX shares gained by 2.70% in over the last four-week period, additionally plugging by 20.02% over the last 6 months – not to mention a rise of 65.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BSX stock in for the last two-week period is set at 68.60, with the RSI for the last a single of trading hit 71.97, and the three-weeks RSI is set at 66.53 for Boston Scientific Corp [BSX]. The present Moving Average for the last 50 days of trading for this stock 85.42, while it was recorded at 88.50 for the last single week of trading, and 76.04 for the last 200 days.
Boston Scientific Corp [BSX]: An insightful look at the core fundamentals
Boston Scientific Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.02 and a Current Ratio set at 1.48.
Earnings per share (EPS) analysis for Boston Scientific Corp [BSX] stock
With the latest financial reports released by the company, Boston Scientific Corp posted 0.55/share EPS, while the average EPS was predicted by analysts to be reported at 0.51/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BSX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Boston Scientific Corp go to 14.20%.
Boston Scientific Corp [BSX]: Institutional Ownership
There are presently around $92.46%, or 92.63%% of BSX stock, in the hands of institutional investors. The top three institutional holders of BSX stocks are: FMR LLC with ownership of 141.46 million shares, which is approximately 9.6337%. VANGUARD GROUP INC, holding 129.87 million shares of the stock with an approximate value of $$10.0 billion in BSX stocks shares; and VANGUARD GROUP INC, currently with $$9.74 billion in BSX stock with ownership which is approximately 8.6093%.
